These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2096279)

  • 1. Cyclosporine therapy in inflammatory bowel disease: open-label experience.
    Lichtiger S
    Mt Sinai J Med; 1990 Oct; 57(5):315-9. PubMed ID: 2096279
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine in inflammatory bowel disease.
    Brynskov J; Binder V; Riis P; Lauritsen K; Schaffalitzky de Muckadell O; Freund L; Fallingborg J; Nørby Rasmussen S; Matzen P; Krag E
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):309. PubMed ID: 3381289
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cyclosporin in intestinal inflammatory disease].
    Vargas V; Guarner L; Accarino A; Sanjosé A
    Med Clin (Barc); 1985 Sep; 85(7):301. PubMed ID: 4058091
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine therapy for inflammatory bowel disease.
    Sartor RB
    N Engl J Med; 1994 Jun; 330(26):1897-8. PubMed ID: 8196735
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cyclosporine A and chronic inflammatory diseases of the digestive tract].
    Brazier F; Finet L; Duchmann JC; Dupas JL
    Gastroenterol Clin Biol; 1995 May; 19(5):494-504. PubMed ID: 7590001
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous cyclosporine for inflammatory bowel disease--safe and effective.
    Chermesh I; Tamir A; Lachter J; Eliakim R
    Hepatogastroenterology; 2007; 54(79):2003-6. PubMed ID: 18251148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
    Dejaco C; Gasché C; Reinisch W; Moser G; Novacek G; Tillinger W; Vogelsang H; Gangl A
    Wien Klin Wochenschr; 1998 Sep; 110(16):579-84. PubMed ID: 9782579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial.
    Biancone L; Tosti C; Geremia A; Fina D; Petruzziello C; Emerenziani S; Pallone F
    Aliment Pharmacol Ther; 2004 Apr; 19(7):755-64. PubMed ID: 15043516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of chronic inflammatory bowel diseases. Basic drug therapy].
    Riemann JF
    Verh Dtsch Ges Inn Med; 1988; 94():175-8. PubMed ID: 3061190
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cyclosporin--a solution or dead end in treatment of chronic inflammatory bowel diseases?].
    Fischbach W
    Z Gastroenterol; 1995 May; 33(5):275-6. PubMed ID: 7610696
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunosuppressive therapy of inflammatory bowel disease: a historical perspective.
    Korelitz BI
    Gastroenterologist; 1995 Jun; 3(2):141-52. PubMed ID: 7640945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New developments and trends in the drug therapy of chronic inflammatory bowel diseases].
    Ewe K
    Verh Dtsch Ges Inn Med; 1988; 94():178-84. PubMed ID: 2905098
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of chronic inflammatory bowel diseases. Long-term ambulatory care].
    Rohr G
    Verh Dtsch Ges Inn Med; 1988; 94():212-5. PubMed ID: 3144811
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current therapeutic possibilities in chronic inflammatory intestinal diseases].
    Schölmerich J
    Praxis (Bern 1994); 1995 Jan; 84(2):29-33. PubMed ID: 7839043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of inflammatory bowel disease, including use of immunosuppressive agents.
    Korelitz BI
    Clin Gastroenterol; 1980 May; 9(2):331-49. PubMed ID: 6104550
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of sulfasalazine in the treatment of inflammatory bowel disease.
    Spector R
    J Iowa Med Soc; 1983 Jun; 73(6):230-4. PubMed ID: 6135735
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug safety, acceptance and effectiveness of 5-aminosalicylic acid (mesalazine) in the treatment of ulcerative colitis and Crohn disease].
    Bayerdörffer E; Bock H
    Leber Magen Darm; 1988 Apr; 18(2):104-13. PubMed ID: 3374251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is pathogenetically-founded therapy of chronic inflammatory bowel disease in sight?].
    Miller B
    Z Gastroenterol; 1993 Nov; 31 Suppl 5():30-4. PubMed ID: 8197797
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inflammatory bowel diseases].
    Kruis W
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S73-5. PubMed ID: 15368174
    [No Abstract]   [Full Text] [Related]  

  • 20. Sulfasalazine therapy in inflammatory bowel disease.
    Das KM
    Gastroenterol Clin North Am; 1989 Mar; 18(1):1-20. PubMed ID: 2563989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.